Anlin Peng
Overview
Explore the profile of Anlin Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
562
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang D, He T, Shi T, Huang K, Peng A
Front Pharmacol
. 2025 Mar;
16:1553853.
PMID: 40083376
Peptide-drug conjugates (PDCs) represent an emerging class of targeted therapeutic agents that consist of small molecular drugs coupled to multifunctional peptides through cleavable or non-cleavable linkers. The principal advantage of...
2.
Yu L, Li X, Shi T, Li N, Zhang D, Liu X, et al.
Int J Biol Macromol
. 2025 Jan;
297:139875.
PMID: 39818366
Parkinson's disease (PD), a neurodegenerative disorder without cure, is characterized by the pathological aggregation of α-synuclein (α-Syn) in Lewy bodies. Classic deposition pathway and condensation pathway contribute to α-Syn aggregation,...
3.
Fan Y, Yuan Y, Xiong M, Jin M, Zhang D, Yang D, et al.
Theranostics
. 2023 Nov;
13(15):5348-5364.
PMID: 37908721
Increased methylation of key genes has been observed in kidney diseases, suggesting that the ten-eleven translocation (Tet) methyl-cytosine dioxygenase family as well as 5mC oxidation may play important roles. As...
4.
Chen Y, Shi J, Wang X, Zhou L, Wang Q, Xie Y, et al.
Proc Natl Acad Sci U S A
. 2023 Sep;
120(39):e2306288120.
PMID: 37729198
Nonsmall cell lung cancer (NSCLC) is highly malignant with limited treatment options, platinum-based chemotherapy is a standard treatment for NSCLC with resistance commonly seen. NSCLC cells exploit enhanced antioxidant defense...
5.
Yang C, Xu H, Yang D, Xie Y, Xiong M, Fan Y, et al.
Nat Commun
. 2023 Jul;
14(1):4261.
PMID: 37460623
Acute kidney injury (AKI) exhibits high morbidity and mortality. Kidney injury molecule-1 (KIM1) is dramatically upregulated in renal tubules upon injury, and acts as a biomarker for various renal diseases....
6.
Xiong M, Chen H, Fan Y, Jin M, Yang D, Chen Y, et al.
Theranostics
. 2023 Jun;
13(10):3387-3401.
PMID: 37351176
Ischemia-reperfusion injury (I/R) is a common cause of acute kidney injury (AKI). Post-ischemic recovery of renal blood supply plays an important role in attenuating injury. Exogenous application of elabela (ELA)...
7.
Ma L, Li X, Petersen R, Peng A, Huang K
Biophys Chem
. 2023 Mar;
296:106984.
PMID: 36889133
Protein misfolding diseases (PMDs) in humans are characterized by the deposition of protein aggregates in tissues, including Alzheimer's disease, Parkinson's disease, type 2 diabetes, and amyotrophic lateral sclerosis. Misfolding and...
8.
Ma L, Li X, Liu C, Yan W, Ma J, Petersen R, et al.
Curr Pharm Des
. 2022 Sep;
28(37):3033-3048.
PMID: 36111767
Parkinson's disease (PD) is a common neurodegenerative disease that affects the motor system and progressively worsens with age. Current treatment options for PD mainly target symptoms, due to our limited...
9.
Liu C, Yan W, Shi J, Wang S, Peng A, Chen Y, et al.
Front Nutr
. 2022 Jul;
9:927092.
PMID: 35811982
The Coronavirus Disease 2019 (COVID-19) showed worse prognosis and higher mortality in individuals with obesity. Dyslipidemia is a major link between obesity and COVID-19 severity. Statins as the most common...
10.
Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C, et al.
Diabetes Care
. 2020 May;
43(7):1399-1407.
PMID: 32409498
Objective: Diabetes is one of the most distinct comorbidities of COVID-19. Here, we describe the clinical characteristics of and outcomes in patients with diabetes in whom COVID-19 was confirmed or...